Senior Research Technician

Location
Australia
Posted
May 12, 2019
Closes
May 28, 2019
Ref
110843
Organization Type
University and College
Hours
Full Time
The University of Queensland Diamantina Institute

The University of Queensland Diamantina Institute (UQDI) was established in 2007 and forms a major research centre within the Faculty of Medicine. The aim of the Institute is to develop a better understanding of the molecular and cellular basis of disease, and to translate that understanding into practical outcomes for patients. Based at the Translational Research Institute (TRI) at the Princess Alexandra Hospital teaching campus in Brisbane, UQDI has more than 300 researchers, clinical academics and students who work closely with hospital clinicians in the areas of cancer, immunology, genomics and other areas of translational medicine. UQDI has particular research strengths in skin cancer, analysis of complex genetic traits and autoimmunity.

UQDI has a mission of translating discoveries into better treatments and has a strong record of achievement, most notably in the development of cancer therapies: research at UQDI by Professor Ian Frazer AC FRS led to the development of the cervical cancer vaccine Gardasil. UQDI is the largest partner in the TRI, which is an extremely well-equipped translational biomedical research institute, with outstanding laboratories and core facilities for imaging, microscopy, flow-cytometry and in vivo models of disease. Its close affiliation with clinical units at Princess Alexandra Hospital provides UQDI with a significant strategic advantage in near-patient, translational research.

UQDI is part of The University of Queensland, one of the top Australasian universities, and internationally is ranked in the top 100 universities in all major independent rankings. UQDI academics are part of a vibrant and highly successful academic institution optimising their chances of research success. Details of the research interests of academic staff may be accessed on the Institute's web site at at http://www.di.uq.edu.au/research

The Role

The successful appointee will support research focused on understanding the pathogenesis and development of novel treatments for autoimmune type 1 diabetes using protein, molecular and immunological techniques.

The Person

Applicants should possess a science degree with honours (or equivalent) in a relevant biological science. You will have practical laboratory experience in immunology, protein science and/or molecular techniques, experience handling biological specimens and understanding of basi lab safety. It would be advantageous if you had experience in proteomic sample preparation, DNA isolation and sequencing and flow cytometry.

The University of Queensland values diversity and inclusion and actively encourages applications from those who bring diversity to the University. Please refer to the University's Diversity and Inclusion webpage ( https://staff.uq.edu.au/information-and-services/human-resources/diversity ) for further information and points of contact if you require additional support.

This role is a full-time position; however flexible working arrangements may be negotiated.

Accessibility requirements and/or adjustments can be directed to med.hr@uq.edu.au

Remuneration

This is a full-time, fixed term appointment for 12 months years at HEW Level 5. The remuneration package will be in the range $67,608 - $75,506 p.a., plus employer superannuation contributions of up to 17% (total package will be in the range $79,101 - $88,342 p.a.).

Enquiries

To discuss this role please contact Dr Emma Hamilton-Williams on (07) 3443 6989 or e.hamiltonwilliams@uq.edu.au

To submit an application for this role, use the Apply button below. All applicants must supply the following documents: Cover letter, Resume and Selection Criteria responses.

For information on completing the application process click here .

You must have valid Australian work rights to apply for this role. Visa sponsorship is not available for this position.

Similar jobs

Similar jobs